|Coronavirus Disease (COVID-19)|
Coronavirus Disease (COVID-19) Update
- House Democrats' new COVID-19 relief bill
- House Democrats' new COVID-19 relief bill summary
- Senate HELP Committee Hearing - COVID-19: Safely Getting Back to Work and Back to School
- Senate HELP Committee Hearing Written Testimony: Fauci, Redfield, Giroir, and Hahn
- CARES Act Provider Relief Fund Main Information Page
- Terms and Conditions for Provider Relief Fund Distributions
- Senate Judiciary Committee Hearing - Examining Liability During the COVID-19 Pandemic
- Senate Judiciary Committee calls for national safety guidelines amid liability hearing
- Senate Banking Committee Hearing on Oversight of Financial Regulators - Comments by Federal Reserve Vice Chair for Supervision
- Federal Reserve takes additional actions to provide up to $2.3 trillion in loans to support the economy
- Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
- Gilead Voluntary Licensing Agreements for Remdesivir
- Burgess Calls on Eshoo to Hold Hearing on Racial Disparities in COVID-19 Outcomes
- Rep. Burgess letter asking for hearing on pandemic-related mental health
- House Democrats released a new COVID-19 relief bill (and summary). The bill includes about $3 trillion in new relief measures.
- About one-third of that funding would be allocated to state, local and territorial governments.
- The bill would provide more direct payments to individuals and families. Specifically, up to $1,200 to individual tax filers, $6,000 for joint filers and $1,200 for each dependent child.
- It would extend the temporary $600 weekly unemployment insurance increase until January.
- It would fund hazard pay to essential workers and new testing and contact tracing programs.
- The bill would increase employee tax credits for employers from $5,000 per worker to $12,000 per worker, per quarter.
- The bill provides $100 billion in funding for primary, secondary and postsecondary education.
- It would provide funding to federal and state public health programs to improve data collection on racial and ethnic disparities.
- The House could vote on the bill as early as Friday. However, it is not expected to receive any Republican support. What’s more, Senate Majority Leader Mitch McConnell (R-KY) and President Trump both oppose the bill meaning it will not become law even if it passes the House. However, elements of this bill could be included in a compromised, bipartisan relief bill that could emerge over the coming weeks.
- Today, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing how to reopen the country. The witnesses included FDA Commissioner Dr. Stephen Hahn, CDC Director Dr. Robert Redfield, NIAID Director Dr. Anthony Fauci and Assistant Secretary of HHS. Adm. Brett Giroir.
- Dr. Fauci warned about the dangers of reopening too early. Dr. Fauci also expressed cautious optimism that at least one of the many COVID-19 vaccines being tested will be successful.
- Adm. Giroir, who is overseeing the federal government’s testing efforts, said his goal is to have the capability to provide 40-50 million tests per month by September.
- The written testimony for all four witnesses and a video recording of the hearing is available on the hearing website.
- The HHS Provider Relief Fund added terms and conditions for providers who receive funding under the rural provider and high impact hospital allocations.
- The Senate Judiciary Committee held a hearing on liability protections as the country begins to reopen. Many of the Committee members expressed support for national liability protections for employers and healthcare professionals.
- During a Senate Banking Committee Hearing, the Federal Reserve’s Vice Chair for Supervision said the Fed expects to release more details about its Main Street Lending Program and its municipal lending program in the next few weeks.
- Gilead Sciences announced it has reached licensing agreements with several generic drug manufacturers to aid in the production of its Remdesivir treatment.
- Rep. Michael Burgess (R-TX), Ranking Member of the House Energy and Commerce (E&C) Committee Subcommittee, asked Subcommittee Chair Rep. Anna Eshoo (D-CA) to hold a hearing on racial and ethnic disparities for COVID-19. Rep. Burgess also asked for a hearing on pandemic-related mental health.